Zhao Xiao-Su について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Zhao Xiao-Su について
Peking-Tsinghua Center for Life Sciences, Beijing, China について
Liu Yan-Rong について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Xu Lan-Ping について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Wang Yu について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Wang Yu について
Peking-Tsinghua Center for Life Sciences, Beijing, China について
Zhang Xiao-Hui について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Zhang Xiao-Hui について
Peking-Tsinghua Center for Life Sciences, Beijing, China について
Chen Huan について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Chen Yu-Hong について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Han Wei について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Sun Yu-Qian について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Yan Chen-Hua について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Mo Xiao-Dong について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Wang Ya-Zhe について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Fan Qiao-Zhen について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Wang Xin-Yu について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Liu Kai-Yan について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Huang Xiao-Jun について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Huang Xiao-Jun について
Collaborative Innovation Center of Hematology, Peking University, Beijing, China について
Chang Ying-Jun について
Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China について
Chang Ying-Jun について
Collaborative Innovation Center of Hematology, Peking University, Beijing, China について
American Journal of Hematology について
多変量解析 について
ヒト について
母集団 について
半数体 について
再発 について
白血病 について
ハプロタイプ について
フローサイトメトリー について
転帰 について
被験者 について
スコア について
リスクスコア について
後向き研究 について
急性リンパ性白血病 について
患者予後 について
同種移植片 について
血液の腫よう について
移植 について
残存 について
疾患 について
ハプロタイプ について
同種移植片 について
患者の転帰 について
予測 について